Wall Street Journal Editorial Today

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Wall Street Journal Editorial Today

Postby JoanCT » Mon Mar 06, 2006 10:50 am

Long URL but it should work for a week:

http://online.wsj.com/wsjgate?subURI=%2 ... TYwWj.html

Refers to Erbitux and Tysabri
User avatar
Posts: 3
Joined: Wed Feb 02, 2005 4:00 pm


Re: Wall Street Journal Editorial Today

Postby HarryZ » Mon Mar 06, 2006 11:27 am


This possible side effect wasn't entirely surprising, given that MS is a degenerative neurological disorder caused by immune system dysfunction.

Gee....I didn't know they finally found the cause of this lousy disease!!! Maybe this reporter knows more than the researchers do :?

User avatar
Family Elder
Posts: 2570
Joined: Tue May 25, 2004 3:00 pm
Location: London, ON, Canada

Return to Tysabri (Antegren or Natalizumab)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service